These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2469085)

  • 1. Neurokinin-alpha injected into the ventral tegmental area elicits a dopamine-dependent behavioral activation in the rat.
    Burns LH; Kelley AE
    Pharmacol Biochem Behav; 1988 Oct; 31(2):255-63. PubMed ID: 2469085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance K, a novel tachykinin injected bilaterally into the ventral tegmental area of rats increases behavioral response.
    Takano Y; Takeda Y; Yamada K; Kamiya H
    Life Sci; 1985 Dec; 37(26):2507-14. PubMed ID: 2417083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin, substance P, neurokinin-alpha, and enkephalin: injection into ventral tegmental area in the rat produces differential effects on operant responding.
    Kelley AE; Cador M; Stinus L; Le Moal M
    Psychopharmacology (Berl); 1989; 97(2):243-52. PubMed ID: 2471221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P and neurokinin A induced desensitization to cardiovascular and behavioral effects: evidence for the involvement of different tachykinin receptors.
    Culman J; Tschöpe C; Jost N; Itoi K; Unger T
    Brain Res; 1993 Oct; 625(1):75-83. PubMed ID: 7694777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
    Tauer U; Zhao Y; Hunt SP; Culman J
    Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
    Deschamps K; Couture R
    Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.
    Elliott PJ; Mason GS; Stephens-Smith M; Hagan RM
    Neuropeptides; 1991 Jun; 19(2):119-26. PubMed ID: 1719444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between D-ala-met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the rat.
    Kelley AE; Stinus L; Iversen SD
    Behav Brain Res; 1980 Feb; 1(1):3-24. PubMed ID: 6269560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced dopamine metabolism in accumbens leads to motor activity and concurrently to increased output from nondopamine neurons in ventral tegmental area and substantia nigra.
    Olds ME
    Physiol Behav; 1992 Jan; 51(1):39-50. PubMed ID: 1311110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats.
    Itoi K; Tschöpe C; Jost N; Culman J; Lebrun C; Stauss B; Unger T
    Eur J Pharmacol; 1992 Sep; 219(3):435-44. PubMed ID: 1385176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance K and substance P in the ventral tegmental area.
    Kalivas PW; Deutch AY; Maggio JE; Mantyh PW; Roth RH
    Neurosci Lett; 1985 Jun; 57(3):241-6. PubMed ID: 2412193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P injections into the ventral tegmentum affect unit activity in mesolimbic terminal regions.
    West CH; Michael RP
    Brain Res Bull; 1991 Feb; 26(2):229-33. PubMed ID: 1707328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area or substantia nigra of rat brain.
    Eison AS; Eison MS; Iversen SD
    Brain Res; 1982 Apr; 238(1):137-52. PubMed ID: 6177380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons.
    Hand TH; Hu XT; Wang RY
    Brain Res; 1987 Jul; 415(2):257-69. PubMed ID: 3607497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurokinin-3 receptor (NK3R) antagonist SB222200 prevents the apomorphine-evoked surface but not nuclear NK3R redistribution in dopaminergic neurons of the rat ventral tegmental area.
    Hether S; Misono K; Lessard A
    Neuroscience; 2013 Sep; 247():12-24. PubMed ID: 23673279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.
    Culman J; Wiegand B; Spitznagel H; Klee S; Unger T
    Br J Pharmacol; 1995 Mar; 114(6):1310-6. PubMed ID: 7542533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of non-dopamine cells in the ventral tegmental area by benzodiazepines: relationship to A10 dopamine cell activity.
    O'Brien DP; White FJ
    Eur J Pharmacol; 1987 Oct; 142(3):343-54. PubMed ID: 2892684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat.
    Kalivas PW; Duffy P; Latimer LG
    J Pharmacol Exp Ther; 1987 Sep; 242(3):757-63. PubMed ID: 3498816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
    Cox RF; Waszczak BL
    Brain Res; 1990 Nov; 534(1-2):273-82. PubMed ID: 1981482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.